Posner Christopher
SEC insider (Form 3/4/5 filer). CIK 0001748265. PRESIDENT AND CEO at Cara Therapeutics, Inc. (CARA). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2025. Located in STAMFORD, CT.
Companies Posner Christopher has filed insider reports for
- Cara Therapeutics, Inc. (CARA): Director, Officer, PRESIDENT AND CEO
Posner Christopher
CIK: 0001748265
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CARA
Cara Therapeutics, Inc.
DirectorOfficer